TRANS-ID tapering : Transitions In Depressive symptoms during tapering of antidepressants<br>

Completed

• Conditions: Depressive symptoms; feeling down; mood transitions; 10027946

• Registration Number: NL-OMON45304
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 45

Inclusion Criteria

- age >= 18
- fulfil the criteria of a past depressive episode according to DSM-IV criteria
- having made a shared decision with a mental health care provider (general practitioner, psychiatrist or a mental health care provider that is supervised by a general practitioner or psychiatrist) to taper the current dose of antidepressant medication
- having made a tapering scheme or plan with a mental health care provider

Exclusion Criteria

- current depressive episode according to the DSM-IV criteria
- presence of bipolar disorder or a psychotic disorder
- reported diagnosis of a personality disorder
- start of any other antidepressant treatment
- inability to work with a smartphone
- not giving informed consent on checking the tapering scheme or plan with the mental health care provider

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter is a within-person critical transition towards higher<br /><br>levels of depressive symptoms. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secundary study parameters are daily affect, behavior, context, Heart Rate<br /><br>Variability, and physical activity. </p><br>